Cargando…
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
Molecular genetic testing for hereditary hemochromatosis (HH) is recognized as a reference test to confirm the diagnosis of suspected HH or to predict its risk. The vast majority (typically >90%) of patients with clinically characterized HH are homozygous for the p.C282Y variant in the HFE gene,...
Autores principales: | Porto, Graça, Brissot, Pierre, Swinkels, Dorine W, Zoller, Heinz, Kamarainen, Outi, Patton, Simon, Alonso, Isabel, Morris, Michael, Keeney, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929861/ https://www.ncbi.nlm.nih.gov/pubmed/26153218 http://dx.doi.org/10.1038/ejhg.2015.128 |
Ejemplares similares
-
EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020) -
EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013) -
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020) -
EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
por: Traeger-Synodinos, Joanne, et al.
Publicado: (2015) -
Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes
por: Beygo, Jasmin, et al.
Publicado: (2019)